All Viruses articles – Page 7
-
NewsAn antidiabetic helps the immune system recognize reservoirs of HIV
Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral therapy, a new study reveals.
-
NewsConscience announces top performers in open science challenge to design promising pan-coronavirus drugs
The nonprofit drug discovery biotech Conscience has released seven newly discovered promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, not just SARS-CoV-2.
-
NewsScientists discover dual roles of antibodies in COVID-19 infections
A new study has discovered an antibody that can both assist and block a virus. This particular antibody helps pre-Omicron variants of the virus infect cells while preventing the Omicron variant from doing the same.
-
CareersCaleb investigates the potential for wastewater surveillance of yellow fever virus in his Summer Placement
Second year medical student Caleb Morin reveals what happened during his Applied Microbiology International-sponsored Summer Placement at the University of Galway investigating wastewater surveillance for monitoring yellow fever virus.
-
NewsStudy identifies areas of Europe at risk from dengue fever
As Europe grapples with the growing threat of tropical diseases brought by the Asian tiger mosquito, a research breakthrough is enabling scientists to accurately predict towns across the continent where there is a high risk of dengue fever.
-
NewsScientists deploy sound waves as acoustic tweezers to separate viruses from saliva
Researchers have described a platform that uses sound waves as acoustic tweezers to sort viruses from other compounds in a liquid. In demonstrations, the method quickly and accurately separates viruses from large and small particles in human saliva samples.
-
NewsScientists close in on mystery of deadly Hep C virus
A new study by a cross-disciplinary research team has identified the protein complex at the surface of the hepatitis C virus that enables it to bind to human cells, opening a pathway to vaccine candidates that can prevent the virus from infecting the cells.
-
NewsDiagnostic tool identifies puzzling inflammatory diseases in kids
A new diagnostic tool can accurately determine if a patient has Kawasaki disease (KD), Multisystem Inflammatory Syndrome in Children (MIS-C), a viral infection or a bacterial infection, while simultaneously monitoring the patient’s organ health.
-
NewsStudy of mosquito spit could lead to therapies for viruses like West Nile and yellow fever
Researchers are analyzing samples of noninfectious mosquito saliva in the fight against arboviruses — viruses spread by arthropods like mosquitoes.
-
NewsNew phage editing technology could lead to alternative treatments for antibiotic-resistant bacteria
Scientists have developed a technology that lets them edit the genomes of phages in a streamlined and highly effective way, giving them the ability to engineer new phages and study how the viruses can be used to target specific bacteria.
-
NewsFirst sustained remission of HIV infection following a bone marrow transplant in the absence of protective mutation
A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection after receiving a bone marrow transplant to treat blood cancer. ...
-
NewsKorea University Vaccine Innovation Center teams with Moderna on mRNA-based hantavirus vaccine development
The Vaccine Innovation Center at Korea University College of Medicine has entered into a full-scale collaboration with global pharmaceutical company Moderna to develop an mRNA-based hantavirus vaccine.
-
NewsChristian Gaebler receives ERC Starting Grant to study HIV patients living without medication
Prof. Christian Gaebler aims to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, and has won funding to study patients who are already living without medication.
-
NewsRSV vaccination in older adults with health conditions is cost-effective
Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study.
-
NewsSaline nasal drops reduce the duration of the common cold in young children by two days
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the European Respiratory Society (ERS) Congress.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsImmune cells prevent lung healing after viral infection
Investigators have discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19.
-
NewsObesity may increase susceptibility to contracting COVID-19
Electronic health record data revealed that individuals with obesity were 34% more likely to become COVID positive after reported exposure than individuals without obesity.
-
NewsFirst phase of polio campaign concludes successfully in Gaza
More than 187,000 children under ten years of age were vaccinated with novel oral polio vaccine type 2 (nOPV2) in central Gaza during the first phase of a two-round polio vaccination campaign, conducted between 1–3 September 2024.
-
NewsInvestigational mpox mRNA vaccine reduces disease severity in primates compared to available vaccines
A new mpox vaccine candidate more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA) vaccine.
